A therapeutic approach that increases EC-SOD protein accumulation, either by overexpression or a therapeutic supplement, could be used prophylactically in patients with long term pathological conditions and chronic disease such as COPD, pulmonary hypertension, sleep disordered breathing and sickle cell disease, all of which are associated with compromised brain oxygenation. The gene discussed is SOD3; the disease is sickle cell disease.